Trials / Withdrawn
WithdrawnNCT00600236
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | blood sample |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2008-01-24
- Last updated
- 2024-06-03
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00600236. Inclusion in this directory is not an endorsement.